DSM N.V. : DSM acquires Microbia, Inc. to expand its leading position in specialty ingredients

Wed Sep 22, 2010 2:15am EDT

* Reuters is not responsible for the content in this press release.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in
the Netherlands, today announces the acquisition of Microbia, Inc. (Lexington,
Massachusetts, United States) from Ironwood Pharmaceuticals, Inc. The terms of the
acquisition will not be disclosed. 


Microbia is a successful industrial biotechnology research and development specialist.
It has developed a highly effective technology platform that enables it to produce
high-quality, natural carotenoids (including β-carotene and canthaxanthin), nutritional
products and other specialty materials and chemicals from renewable resources. 


Microbia's sales are still limited. The acquisition will allow DSM to incorporate
Microbia's proprietary platform and world class research and development capabilities
and support DSM's ongoing development of the natural carotenoids market.


Leendert Staal, President and CEO of DSM Nutritional Products commented: "The
acquisition of Microbia represents a significant step for DSM in our strategy to
accelerate our innovation activities in natural products and fermentation processes.
This acquisition allows us to expand our product portfolio as well as our research and
development capabilities."


Kevin Madden, Chief Science Officer of Microbia added, "We are thrilled to join DSM.
Being part of a large global organization, and a world leader in industrial
biotechnology, vitamins and carotenoid development, manufacturing and sales will
expedite our ability to leverage our proprietary bio-based technology platform. We look
forward to help accelerate DSM's ongoing efforts to develop, produce and commercialize
the next generation of nutritional ingredients and other materials that will help the
food, feed, chemicals and other industries produce more innovative and sustainable
products, in a far more cost effective and responsible manner."


About Microbia
Microbia, Inc. (formerly Microbia Precision Engineering) is an industrial biotechnology
company applying proprietary metabolic engineering utilizing fermentation technology to
create natural, cost-effective, renewable specialty ingredients and biomaterials.


About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and
other fine chemicals to the feed, food, pharmaceutical and personal care industries. The
business has sales of over EUR 2 billion and a long tradition as a pioneer in the
discovery of new products, new formulations and attractive applications for all industry
segments. For further company information please visit www.dsmnutritionalproducts.com 


DSM - the Life Sciences and Materials Sciences Company 
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end
markets include human and animal nutrition and health, personal care, pharmaceuticals,
automotive, coatings and paint, electrical and electronics, life protection and housing.
DSM manages its business with a focus on the triple bottom line of economic performance,
environmental quality and social responsibility, which it pursues simultaneously and in
parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people
worldwide. The company is headquartered in the Netherlands, with locations 
http://www.dsm.com/en_US/html/about/location_finder.htm   on five continents. DSM is
listed on Euronext Amsterdam. More information: www.dsm.com  http://www.dsm.com/  


For more information:

 DSM Corporate Communications Herman Betten                       DSM Investor Relations  Hans Vossen                                     
 tel. +31 (0) 45 5782017                                          tel. +31 (0) 45 5782864                                                 
 fax +31 (0) 45 5740680                                           fax +31 (0) 10 4590275                                                  
 e-mail media.relations@dsm.com  mailto:media.relations@dsm.com    e-mail investor.relations@dsm.com  mailto:investor.relations@dsm.com   

DSM Investor Relations

Hans Vossen
tel. +31 (0) 45 5782864
fax +31 (0) 10 4590275
 e-mail investor.relations@dsm.com  mailto:investor.relations@dsm.com


Press release-pdf  http://hugin.info/130663/R/1445921/389029.pdf

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.